Concepedia

Publication | Open Access

Efficacy of Osimertinib Plus Bevacizumab vs Osimertinib in Patients With <i>EGFR</i> T790M–Mutated Non–Small Cell Lung Cancer Previously Treated With Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitor

178

Citations

17

References

2021

Year

Abstract

UMIN Clinical Trials Registry Identifier: UMIN000023761.

References

YearCitations

Page 1